174 related articles for article (PubMed ID: 31838196)
21. Epoxyeicosatrienoic acid pathway in human health and diseases.
Bellien J; Joannides R
J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
[TBL] [Abstract][Full Text] [Related]
22. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.
Fleming I
Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of disease-mediated therapeutic protein-drug interactions between an anti-interleukin-6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach.
Zhuang Y; de Vries DE; Xu Z; Marciniak SJ; Chen D; Leon F; Davis HM; Zhou H
J Clin Pharmacol; 2015 Dec; 55(12):1386-94. PubMed ID: 26054042
[TBL] [Abstract][Full Text] [Related]
24. Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury.
Birnie M; Morrison R; Camara R; Strauss KI
BMC Genomics; 2013 May; 14():303. PubMed ID: 23642095
[TBL] [Abstract][Full Text] [Related]
25. EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells.
Jiang JX; Zhang SJ; Liu YN; Lin XX; Sun YH; Shen HJ; Yan XF; Xie QM
Eur J Pharmacol; 2014 Mar; 727():43-51. PubMed ID: 24486707
[TBL] [Abstract][Full Text] [Related]
26. Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.
Alsaad AM; Zordoky BN; Tse MM; El-Kadi AO
Drug Metab Rev; 2013 May; 45(2):173-95. PubMed ID: 23600686
[TBL] [Abstract][Full Text] [Related]
27. Role of NF-κB in cytochrome P450 epoxygenases down-regulation during an inflammatory process in astrocytes.
Navarro-Mabarak C; Mitre-Aguilar IB; Camacho-Carranza R; Arias C; Zentella-Dehesa A; Espinosa-Aguirre JJ
Neurochem Int; 2019 Oct; 129():104499. PubMed ID: 31271766
[TBL] [Abstract][Full Text] [Related]
28. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
29. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease' PUFA, inflammatory processes and rheumatoid arthritis.
Calder PC
Proc Nutr Soc; 2008 Nov; 67(4):409-18. PubMed ID: 18847518
[TBL] [Abstract][Full Text] [Related]
30. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry.
Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ
J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension.
Wang MH; Smith A; Zhou Y; Chang HH; Lin S; Zhao X; Imig JD; Dorrance AM
Hypertension; 2003 Oct; 42(4):594-9. PubMed ID: 12939236
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P450-derived eicosanoids in brain: From basic discovery to clinical translation.
Davis CM; Ibrahim AH; Alkayed NJ
Adv Pharmacol; 2023; 97():283-326. PubMed ID: 37236762
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome P450-dependent eicosanoid production and crosstalk.
Fleming I
Curr Opin Lipidol; 2011 Oct; 22(5):403-9. PubMed ID: 21825980
[TBL] [Abstract][Full Text] [Related]
34. CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy.
Chen C; Wang DW
Curr Top Med Chem; 2013; 13(12):1454-69. PubMed ID: 23688135
[TBL] [Abstract][Full Text] [Related]
35. Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids.
Medhora M; Dhanasekaran A; Gruenloh SK; Dunn LK; Gabrilovich M; Falck JR; Harder DR; Jacobs ER; Pratt PF
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):19-29. PubMed ID: 17164129
[TBL] [Abstract][Full Text] [Related]
36. Eicosanoids, β-cell function, and diabetes.
Luo P; Wang MH
Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):1-10. PubMed ID: 21757024
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.
Johnson AL; Edson KZ; Totah RA; Rettie AE
Adv Pharmacol; 2015; 74():223-62. PubMed ID: 26233909
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 and cytochrome-P450, reason for concern?
Kim S; Östör AJ; Nisar MK
Rheumatol Int; 2012 Sep; 32(9):2601-4. PubMed ID: 22451032
[TBL] [Abstract][Full Text] [Related]
39. Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet.
Zhou Y; Lin S; Chang HH; Du J; Dong Z; Dorrance AM; Brands MW; Wang MH
Am J Hypertens; 2005 Apr; 18(4 Pt 1):530-7. PubMed ID: 15831364
[TBL] [Abstract][Full Text] [Related]
40. Detection of EETs and HETE-generating cytochrome P-450 enzymes and the effects of their metabolites on myometrial and vascular function.
Pearson T; Warren AY; Barrett DA; Khan RN
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E647-56. PubMed ID: 19549792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
